<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/BCD05341-5D48-43F1-A505-C169496883A1"><gtr:id>BCD05341-5D48-43F1-A505-C169496883A1</gtr:id><gtr:name>University of Hong Kong</gtr:name><gtr:address><gtr:line1>Pok Fu Lam Road</gtr:line1><gtr:line4>Hong Kong</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Hong Kong</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2448D059-1C4B-4E76-A4C6-8A3109B8F194"><gtr:id>2448D059-1C4B-4E76-A4C6-8A3109B8F194</gtr:id><gtr:name>University of Gothenburg</gtr:name><gtr:address><gtr:line1>University of Gothenburg</gtr:line1><gtr:line2>PO Box 100</gtr:line2><gtr:line4>Gothenburg</gtr:line4><gtr:line5>SE 405 30</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78778E97-5A2E-40A6-A88F-137A343A3530"><gtr:id>78778E97-5A2E-40A6-A88F-137A343A3530</gtr:id><gtr:name>University of Toronto</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/8F8BCFC1-FF94-4796-B5E0-5A64B0C3AB6C"><gtr:id>8F8BCFC1-FF94-4796-B5E0-5A64B0C3AB6C</gtr:id><gtr:name>Autonomous University of Madrid</gtr:name><gtr:address><gtr:line1>Ciudad Universitaria de Cantoblanco</gtr:line1><gtr:line2>C/Francisco Tomas y Valiente, 1</gtr:line2><gtr:line4>Madrid</gtr:line4><gtr:line5>E-28049</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/B16D710A-5C40-44CA-A796-B37EC8935E99"><gtr:id>B16D710A-5C40-44CA-A796-B37EC8935E99</gtr:id><gtr:name>University of Michigan</gtr:name><gtr:address><gtr:line1>3003 S. State Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F20FFE5B-3DA6-4629-894F-4CE13B49B4E4"><gtr:id>F20FFE5B-3DA6-4629-894F-4CE13B49B4E4</gtr:id><gtr:name>Vanderbilt University</gtr:name><gtr:address><gtr:line1>Vanderbilt University</gtr:line1><gtr:line2>2201 West End Avenue</gtr:line2><gtr:line4>Nashville</gtr:line4><gtr:line5>Tennessee</gtr:line5><gtr:postCode>TN 37235</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:department>Clinical Science at North Bristol</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/BCD05341-5D48-43F1-A505-C169496883A1"><gtr:id>BCD05341-5D48-43F1-A505-C169496883A1</gtr:id><gtr:name>University of Hong Kong</gtr:name><gtr:address><gtr:line1>Pok Fu Lam Road</gtr:line1><gtr:line4>Hong Kong</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Hong Kong</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2448D059-1C4B-4E76-A4C6-8A3109B8F194"><gtr:id>2448D059-1C4B-4E76-A4C6-8A3109B8F194</gtr:id><gtr:name>University of Gothenburg</gtr:name><gtr:address><gtr:line1>University of Gothenburg</gtr:line1><gtr:line2>PO Box 100</gtr:line2><gtr:line4>Gothenburg</gtr:line4><gtr:line5>SE 405 30</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78778E97-5A2E-40A6-A88F-137A343A3530"><gtr:id>78778E97-5A2E-40A6-A88F-137A343A3530</gtr:id><gtr:name>University of Toronto</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/8F8BCFC1-FF94-4796-B5E0-5A64B0C3AB6C"><gtr:id>8F8BCFC1-FF94-4796-B5E0-5A64B0C3AB6C</gtr:id><gtr:name>Autonomous University of Madrid</gtr:name><gtr:address><gtr:line1>Ciudad Universitaria de Cantoblanco</gtr:line1><gtr:line2>C/Francisco Tomas y Valiente, 1</gtr:line2><gtr:line4>Madrid</gtr:line4><gtr:line5>E-28049</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/B16D710A-5C40-44CA-A796-B37EC8935E99"><gtr:id>B16D710A-5C40-44CA-A796-B37EC8935E99</gtr:id><gtr:name>University of Michigan</gtr:name><gtr:address><gtr:line1>3003 S. State Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F20FFE5B-3DA6-4629-894F-4CE13B49B4E4"><gtr:id>F20FFE5B-3DA6-4629-894F-4CE13B49B4E4</gtr:id><gtr:name>Vanderbilt University</gtr:name><gtr:address><gtr:line1>Vanderbilt University</gtr:line1><gtr:line2>2201 West End Avenue</gtr:line2><gtr:line4>Nashville</gtr:line4><gtr:line5>Tennessee</gtr:line5><gtr:postCode>TN 37235</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A0D018F9-FF04-4E19-9699-9089444CDD67"><gtr:id>A0D018F9-FF04-4E19-9699-9089444CDD67</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Mathieson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0500053"><gtr:id>A7D78D5B-F909-4D86-99D2-730342D6B251</gtr:id><gtr:title>The cellular basis of albuminuria</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0500053</gtr:grantReference><gtr:abstractText>Health screening often involves urine testing, which is cheap and cost-effective. Appearance of protein in the urine can be an early sign of kidney disease and has also been found to be associated with an increased risk of heart disease. Normally, two specialised types of kidney cell prevent leakage of protein into the urine. Previously it has been difficult to study these cells in the laboratory because human cells could only be obtained in small numbers and were difficult to keep alive. Therefore, most previous work on this subject has relied on animal experiments. We have developed a way of keeping the relevant human cells alive in the laboratory. We will use these cells to study the ways in which leakage of protein is prevented in the healthy sitation, what goes wrong in disease, and the ways in which this can be reversed or prevented. Our ultimate aim is to develop ways of detecting and treating early kidney and heart disease. These conditions are extremely costly to treat and currently they are often not detected until advanced damage has occurred. Prevention is better than cure!</gtr:abstractText><gtr:technicalSummary>Albuminuria is normally prevented by the actions of two specialised cell types in the kidney, podocytes and glomerular endothelial cells (GEnC). Even small amounts of albuminuria have important clinical connotations: as well as being a sign of possible early kidney disease, including being the earliest sign of kidney injury in diabetes mellitus, albuminuria is an independent risk factor for cardiovascular disease, associated with insulin resistance. The link between these clinical associations may be explained by our recent novel finding that podocytes are insulin-responsive cells. We will study further the effects of insulin on podocytes and GEnC and we will also carry out a detailed analysis of the phenotype and function of these cells in vitro and the interactions between them. In Bristol we have assembled unique tools for this work, including human podocyte and GEnC cell lines which we believe are the best available world-wide for this type of work. We will address six key questions: the role of nephrin in podocyte structure and function; the phenotype and function of our novel GEnC lines; responses of each cell type to insulin and the cellular and molecular mechanisms thereof; ways in which these cells are affected by diabetic conditions; interactions between the two cell types especially the role of key mediators including vascular endothelial growth factor and angiopoietin 1; and development of a co-culture system to mimic as closely as possible the in vivo situation. We show preliminary data to support the feasibility of these approaches. Our unique resources equip us to address questions that cannot be addressed in vivo in man or in experimental animals. Our ultimate aim is to understand cellular and molecular mechanisms underlying albuminuria and its ominous significance so that we can identify novel therapeutic targets and develop preventive strategies.</gtr:technicalSummary><gtr:fund><gtr:end>2008-10-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>585340</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Gothenburg</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Numerous research collaborations world-wide: examples quoted here have resulted in recent publications</gtr:description><gtr:id>239A5847-AB23-4B20-BDCA-B445CFAEB3B1</gtr:id><gtr:impact>Publications including PMIDs 16622173, 17032937, 17272398, 17627784, 18235087, 18256312, 18842989 and now others too numerous to mention. Numerous invitations to Peter Mathieson to speak or chair at prestigious international conferences including American Society of Nephrology (twice), World Congress of Nephrology (twice), serial European Conferences. Our standing in the field led directly to my selection to organise and host the 8th International Podocyte meeting which was held in Bristol in June 2010, the first time that this conference has been held in the UK. a,d was deemed a great success.</gtr:impact><gtr:partnerContribution>Mutual laboratory visits for training and experience in specific techniques, sharing of reagents and data, ongoing research collaboration. Ongoing research collaborationResearch collaborationResearch collaborationResearch collaboration, sharing of reagents &amp;amp; expertiseOngoing research collaborationResearch collaborationJoint publication, ongoing collaboration. Toronto hosted Dr Richard Coward's two year stay as part of his MRC fellowship: he has now returned to Bristol bringing new skills with him.</gtr:partnerContribution><gtr:piContribution>Our unique human glomerular cell lines have been in great demand internationally and we have shared these with over 30 collaborators worldwide. We have ongoing collaborations involving sharing of data, joint publications etc and in some cases laboratory visits in either direction to acquire training and experience in specific techniques.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Autonomous University of Madrid (Universidad Aut?noma de Madrid UAM)</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>Numerous research collaborations world-wide: examples quoted here have resulted in recent publications</gtr:description><gtr:id>A21128C7-CB93-4235-91FC-0454136F808F</gtr:id><gtr:impact>Publications including PMIDs 16622173, 17032937, 17272398, 17627784, 18235087, 18256312, 18842989 and now others too numerous to mention. Numerous invitations to Peter Mathieson to speak or chair at prestigious international conferences including American Society of Nephrology (twice), World Congress of Nephrology (twice), serial European Conferences. Our standing in the field led directly to my selection to organise and host the 8th International Podocyte meeting which was held in Bristol in June 2010, the first time that this conference has been held in the UK. a,d was deemed a great success.</gtr:impact><gtr:partnerContribution>Mutual laboratory visits for training and experience in specific techniques, sharing of reagents and data, ongoing research collaboration. Ongoing research collaborationResearch collaborationResearch collaborationResearch collaboration, sharing of reagents &amp;amp; expertiseOngoing research collaborationResearch collaborationJoint publication, ongoing collaboration. Toronto hosted Dr Richard Coward's two year stay as part of his MRC fellowship: he has now returned to Bristol bringing new skills with him.</gtr:partnerContribution><gtr:piContribution>Our unique human glomerular cell lines have been in great demand internationally and we have shared these with over 30 collaborators worldwide. We have ongoing collaborations involving sharing of data, joint publications etc and in some cases laboratory visits in either direction to acquire training and experience in specific techniques.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Hong Kong</gtr:collaboratingOrganisation><gtr:country>Hong Kong, Special Administrative Region of China</gtr:country><gtr:description>Numerous research collaborations world-wide: examples quoted here have resulted in recent publications</gtr:description><gtr:id>C600EA30-E244-4D5F-B8D4-669EFE2FE53E</gtr:id><gtr:impact>Publications including PMIDs 16622173, 17032937, 17272398, 17627784, 18235087, 18256312, 18842989 and now others too numerous to mention. Numerous invitations to Peter Mathieson to speak or chair at prestigious international conferences including American Society of Nephrology (twice), World Congress of Nephrology (twice), serial European Conferences. Our standing in the field led directly to my selection to organise and host the 8th International Podocyte meeting which was held in Bristol in June 2010, the first time that this conference has been held in the UK. a,d was deemed a great success.</gtr:impact><gtr:partnerContribution>Mutual laboratory visits for training and experience in specific techniques, sharing of reagents and data, ongoing research collaboration. Ongoing research collaborationResearch collaborationResearch collaborationResearch collaboration, sharing of reagents &amp;amp; expertiseOngoing research collaborationResearch collaborationJoint publication, ongoing collaboration. Toronto hosted Dr Richard Coward's two year stay as part of his MRC fellowship: he has now returned to Bristol bringing new skills with him.</gtr:partnerContribution><gtr:piContribution>Our unique human glomerular cell lines have been in great demand internationally and we have shared these with over 30 collaborators worldwide. We have ongoing collaborations involving sharing of data, joint publications etc and in some cases laboratory visits in either direction to acquire training and experience in specific techniques.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lund University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Numerous research collaborations world-wide: examples quoted here have resulted in recent publications</gtr:description><gtr:id>9E249890-C189-452E-89D3-835C7720C174</gtr:id><gtr:impact>Publications including PMIDs 16622173, 17032937, 17272398, 17627784, 18235087, 18256312, 18842989 and now others too numerous to mention. Numerous invitations to Peter Mathieson to speak or chair at prestigious international conferences including American Society of Nephrology (twice), World Congress of Nephrology (twice), serial European Conferences. Our standing in the field led directly to my selection to organise and host the 8th International Podocyte meeting which was held in Bristol in June 2010, the first time that this conference has been held in the UK. a,d was deemed a great success.</gtr:impact><gtr:partnerContribution>Mutual laboratory visits for training and experience in specific techniques, sharing of reagents and data, ongoing research collaboration. Ongoing research collaborationResearch collaborationResearch collaborationResearch collaboration, sharing of reagents &amp;amp; expertiseOngoing research collaborationResearch collaborationJoint publication, ongoing collaboration. Toronto hosted Dr Richard Coward's two year stay as part of his MRC fellowship: he has now returned to Bristol bringing new skills with him.</gtr:partnerContribution><gtr:piContribution>Our unique human glomerular cell lines have been in great demand internationally and we have shared these with over 30 collaborators worldwide. We have ongoing collaborations involving sharing of data, joint publications etc and in some cases laboratory visits in either direction to acquire training and experience in specific techniques.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Numerous research collaborations world-wide: examples quoted here have resulted in recent publications</gtr:description><gtr:id>5210CA12-4D96-45A2-BE54-3B3ABBD8FD91</gtr:id><gtr:impact>Publications including PMIDs 16622173, 17032937, 17272398, 17627784, 18235087, 18256312, 18842989 and now others too numerous to mention. Numerous invitations to Peter Mathieson to speak or chair at prestigious international conferences including American Society of Nephrology (twice), World Congress of Nephrology (twice), serial European Conferences. Our standing in the field led directly to my selection to organise and host the 8th International Podocyte meeting which was held in Bristol in June 2010, the first time that this conference has been held in the UK. a,d was deemed a great success.</gtr:impact><gtr:partnerContribution>Mutual laboratory visits for training and experience in specific techniques, sharing of reagents and data, ongoing research collaboration. Ongoing research collaborationResearch collaborationResearch collaborationResearch collaboration, sharing of reagents &amp;amp; expertiseOngoing research collaborationResearch collaborationJoint publication, ongoing collaboration. Toronto hosted Dr Richard Coward's two year stay as part of his MRC fellowship: he has now returned to Bristol bringing new skills with him.</gtr:partnerContribution><gtr:piContribution>Our unique human glomerular cell lines have been in great demand internationally and we have shared these with over 30 collaborators worldwide. We have ongoing collaborations involving sharing of data, joint publications etc and in some cases laboratory visits in either direction to acquire training and experience in specific techniques.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Michigan</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Numerous research collaborations world-wide: examples quoted here have resulted in recent publications</gtr:description><gtr:id>9108E47D-77F9-4CDD-8AE2-E4A42CAB045F</gtr:id><gtr:impact>Publications including PMIDs 16622173, 17032937, 17272398, 17627784, 18235087, 18256312, 18842989 and now others too numerous to mention. Numerous invitations to Peter Mathieson to speak or chair at prestigious international conferences including American Society of Nephrology (twice), World Congress of Nephrology (twice), serial European Conferences. Our standing in the field led directly to my selection to organise and host the 8th International Podocyte meeting which was held in Bristol in June 2010, the first time that this conference has been held in the UK. a,d was deemed a great success.</gtr:impact><gtr:partnerContribution>Mutual laboratory visits for training and experience in specific techniques, sharing of reagents and data, ongoing research collaboration. Ongoing research collaborationResearch collaborationResearch collaborationResearch collaboration, sharing of reagents &amp;amp; expertiseOngoing research collaborationResearch collaborationJoint publication, ongoing collaboration. Toronto hosted Dr Richard Coward's two year stay as part of his MRC fellowship: he has now returned to Bristol bringing new skills with him.</gtr:partnerContribution><gtr:piContribution>Our unique human glomerular cell lines have been in great demand internationally and we have shared these with over 30 collaborators worldwide. We have ongoing collaborations involving sharing of data, joint publications etc and in some cases laboratory visits in either direction to acquire training and experience in specific techniques.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Toronto</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:department>Samuel Lunenfeld Research Institute</gtr:department><gtr:description>Numerous research collaborations world-wide: examples quoted here have resulted in recent publications</gtr:description><gtr:id>249F5FF6-D58D-4E9D-958E-B2464B7CBF6D</gtr:id><gtr:impact>Publications including PMIDs 16622173, 17032937, 17272398, 17627784, 18235087, 18256312, 18842989 and now others too numerous to mention. Numerous invitations to Peter Mathieson to speak or chair at prestigious international conferences including American Society of Nephrology (twice), World Congress of Nephrology (twice), serial European Conferences. Our standing in the field led directly to my selection to organise and host the 8th International Podocyte meeting which was held in Bristol in June 2010, the first time that this conference has been held in the UK. a,d was deemed a great success.</gtr:impact><gtr:partnerContribution>Mutual laboratory visits for training and experience in specific techniques, sharing of reagents and data, ongoing research collaboration. Ongoing research collaborationResearch collaborationResearch collaborationResearch collaboration, sharing of reagents &amp;amp; expertiseOngoing research collaborationResearch collaborationJoint publication, ongoing collaboration. Toronto hosted Dr Richard Coward's two year stay as part of his MRC fellowship: he has now returned to Bristol bringing new skills with him.</gtr:partnerContribution><gtr:piContribution>Our unique human glomerular cell lines have been in great demand internationally and we have shared these with over 30 collaborators worldwide. We have ongoing collaborations involving sharing of data, joint publications etc and in some cases laboratory visits in either direction to acquire training and experience in specific techniques.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Vanderbilt University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Numerous research collaborations world-wide: examples quoted here have resulted in recent publications</gtr:description><gtr:id>D3A12C0A-F852-48D3-8E94-8C69FB1802FF</gtr:id><gtr:impact>Publications including PMIDs 16622173, 17032937, 17272398, 17627784, 18235087, 18256312, 18842989 and now others too numerous to mention. Numerous invitations to Peter Mathieson to speak or chair at prestigious international conferences including American Society of Nephrology (twice), World Congress of Nephrology (twice), serial European Conferences. Our standing in the field led directly to my selection to organise and host the 8th International Podocyte meeting which was held in Bristol in June 2010, the first time that this conference has been held in the UK. a,d was deemed a great success.</gtr:impact><gtr:partnerContribution>Mutual laboratory visits for training and experience in specific techniques, sharing of reagents and data, ongoing research collaboration. Ongoing research collaborationResearch collaborationResearch collaborationResearch collaboration, sharing of reagents &amp;amp; expertiseOngoing research collaborationResearch collaborationJoint publication, ongoing collaboration. Toronto hosted Dr Richard Coward's two year stay as part of his MRC fellowship: he has now returned to Bristol bringing new skills with him.</gtr:partnerContribution><gtr:piContribution>Our unique human glomerular cell lines have been in great demand internationally and we have shared these with over 30 collaborators worldwide. We have ongoing collaborations involving sharing of data, joint publications etc and in some cases laboratory visits in either direction to acquire training and experience in specific techniques.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>scientific and/or clinical conferences</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>A32CC86C-40FB-4EDF-BC0F-E21C2A3BBCF6</gtr:id><gtr:impact>Numerous occasions

new collaborations, increased interest in our work</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>clinical and/or scientific conferences</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>49CA2C1C-C83B-4F2B-9323-A21FE3845FA1</gtr:id><gtr:impact>Numerous occasions, including prestigious plenary and/or named lectureships

Increased awareness of our work, new collaborations</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>addressing lay audiences</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>70E13321-CA20-4221-831F-D36710FF27E2</gtr:id><gtr:impact>Numerous occasions: I have addressed patients, carers, rotary, church groups, farmers, hunters and fund-raisers

public education, increased interest in our work, contributed to fund-raising for kidney research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Project Grant</gtr:description><gtr:end>2010-01-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>574ABAB0-5706-4F40-8A11-94F0BAA31B07</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2008-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>450000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Programme Grant</gtr:description><gtr:end>2012-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>5EADB29E-8097-4E2E-B5A5-C7332A38FE96</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/41BD90BC-63A2-4AE1-9FC2-F674A7BE17ED"><gtr:id>41BD90BC-63A2-4AE1-9FC2-F674A7BE17ED</gtr:id><gtr:title>Functional expression of the renin-angiotensin system in human podocytes.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Renal physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/93c108a25b7ee890b87d2887958237ba"><gtr:id>93c108a25b7ee890b87d2887958237ba</gtr:id><gtr:otherNames>Liebau MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1522-1466</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/94BAC99F-431B-4185-8532-44ED83A2D0D0"><gtr:id>94BAC99F-431B-4185-8532-44ED83A2D0D0</gtr:id><gtr:title>Sirolimus toxicity and vascular endothelial growth factor release from islet and renal cell lines.</gtr:title><gtr:parentPublicationTitle>Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0daef08ac16396f0f6be0a15f5606da4"><gtr:id>0daef08ac16396f0f6be0a15f5606da4</gtr:id><gtr:otherNames>Laugharne M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0041-1337</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/34D677A0-F642-4745-94A0-39FD1FED35EA"><gtr:id>34D677A0-F642-4745-94A0-39FD1FED35EA</gtr:id><gtr:title>VEGF-C promotes survival in podocytes.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Renal physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b4d4923ca9efeb89ca05cb6f82d9603b"><gtr:id>b4d4923ca9efeb89ca05cb6f82d9603b</gtr:id><gtr:otherNames>Foster RR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1522-1466</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/65C53570-7CEF-4C26-8DBA-F187BD801B68"><gtr:id>65C53570-7CEF-4C26-8DBA-F187BD801B68</gtr:id><gtr:title>Glomerular endothelial glycocalyx constitutes a barrier to protein permeability.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/62669b53e98481724294af0f7a2ae396"><gtr:id>62669b53e98481724294af0f7a2ae396</gtr:id><gtr:otherNames>Singh A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/710847DA-0122-456E-ABF8-8AE9F781E932"><gtr:id>710847DA-0122-456E-ABF8-8AE9F781E932</gtr:id><gtr:title>Interferon-beta reduces proteinuria in experimental glomerulonephritis.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c613e96d10767da12e9f111419f54f17"><gtr:id>c613e96d10767da12e9f111419f54f17</gtr:id><gtr:otherNames>Satchell SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B8445F40-89DA-4C9B-9A78-972DA36704A6"><gtr:id>B8445F40-89DA-4C9B-9A78-972DA36704A6</gtr:id><gtr:title>Identification of the glomerular podocyte as a target for growth hormone action.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ec65ddbfeaefd412f64cc4121c994653"><gtr:id>ec65ddbfeaefd412f64cc4121c994653</gtr:id><gtr:otherNames>Reddy GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CA6AC6A2-64CD-418A-BBAF-0C20F2EB1FF9"><gtr:id>CA6AC6A2-64CD-418A-BBAF-0C20F2EB1FF9</gtr:id><gtr:title>Shiga toxin 2 targets the murine renal collecting duct epithelium.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/69c39ded765a1fb1e11f9de02f1aaaa9"><gtr:id>69c39ded765a1fb1e11f9de02f1aaaa9</gtr:id><gtr:otherNames>Psotka MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F033D281-611C-407C-B09A-189CA4E7495E"><gtr:id>F033D281-611C-407C-B09A-189CA4E7495E</gtr:id><gtr:title>Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF.</gtr:title><gtr:parentPublicationTitle>Kidney international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c613e96d10767da12e9f111419f54f17"><gtr:id>c613e96d10767da12e9f111419f54f17</gtr:id><gtr:otherNames>Satchell SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0085-2538</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/40F49001-CB21-48D1-85C2-4ED88C29AC28"><gtr:id>40F49001-CB21-48D1-85C2-4ED88C29AC28</gtr:id><gtr:title>A novel renal perspective of preeclampsia: a look from the podocyte.</gtr:title><gtr:parentPublicationTitle>Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/20e624ebd7c3f8fcd1772503deaf8c51"><gtr:id>20e624ebd7c3f8fcd1772503deaf8c51</gtr:id><gtr:otherNames>Henao DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0931-0509</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A2E9F47B-E9CA-4676-93C4-82FC5503EC8C"><gtr:id>A2E9F47B-E9CA-4676-93C4-82FC5503EC8C</gtr:id><gtr:title>A proteomic investigation of glomerular podocytes from a Denys-Drash syndrome patient with a mutation in the Wilms tumour suppressor gene WT1.</gtr:title><gtr:parentPublicationTitle>Proteomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/52588a970d8e228c7b4d4774a56f4fe1"><gtr:id>52588a970d8e228c7b4d4774a56f4fe1</gtr:id><gtr:otherNames>Viney RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1615-9853</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F4E6E9BB-DBE3-4049-BDBC-A936B1290EE3"><gtr:id>F4E6E9BB-DBE3-4049-BDBC-A936B1290EE3</gtr:id><gtr:title>Statin-sensitive endocytosis of albumin by glomerular podocytes.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Renal physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/30e1291dd8854c63930af19697ccabe8"><gtr:id>30e1291dd8854c63930af19697ccabe8</gtr:id><gtr:otherNames>Eyre J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1522-1466</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/11E9FCCC-A61C-4078-A355-964F8A989CAA"><gtr:id>11E9FCCC-A61C-4078-A355-964F8A989CAA</gtr:id><gtr:title>Glycosaminoglycan regulation by VEGFA and VEGFC of the glomerular microvascular endothelial cell glycocalyx in vitro.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b4d4923ca9efeb89ca05cb6f82d9603b"><gtr:id>b4d4923ca9efeb89ca05cb6f82d9603b</gtr:id><gtr:otherNames>Foster RR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/31E1D49A-349C-40CB-B8AD-5006017D9052"><gtr:id>31E1D49A-349C-40CB-B8AD-5006017D9052</gtr:id><gtr:title>Vascular endothelial growth factor as a survival factor for human islets: effect of immunosuppressive drugs.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/96fbbe543729cb196aef5674d5bc6835"><gtr:id>96fbbe543729cb196aef5674d5bc6835</gtr:id><gtr:otherNames>Cross SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/80E7CE24-34F8-482C-855D-524C83D15A4A"><gtr:id>80E7CE24-34F8-482C-855D-524C83D15A4A</gtr:id><gtr:title>Vascular endothelial growth factor-C, a potential paracrine regulator of glomerular permeability, increases glomerular endothelial cell monolayer integrity and intracellular calcium.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b4d4923ca9efeb89ca05cb6f82d9603b"><gtr:id>b4d4923ca9efeb89ca05cb6f82d9603b</gtr:id><gtr:otherNames>Foster RR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/ABEF7440-1248-4725-B239-E2254CE569D6"><gtr:id>ABEF7440-1248-4725-B239-E2254CE569D6</gtr:id><gtr:title>Functional distinctions in cytosolic calcium regulation between cells of the glomerular filtration barrier.</gtr:title><gtr:parentPublicationTitle>Cell calcium</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b4d4923ca9efeb89ca05cb6f82d9603b"><gtr:id>b4d4923ca9efeb89ca05cb6f82d9603b</gtr:id><gtr:otherNames>Foster RR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0143-4160</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8B2C3A48-5132-4A9D-91C6-F44DB075E9B7"><gtr:id>8B2C3A48-5132-4A9D-91C6-F44DB075E9B7</gtr:id><gtr:title>Human podocytes adhere to the KRGDS motif of the alpha3alpha4alpha5 collagen IV network.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/826a25c7465d2afb1646f4e48ce371b8"><gtr:id>826a25c7465d2afb1646f4e48ce371b8</gtr:id><gtr:otherNames>Borza CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A00C5921-6001-4D9E-8E10-EC2B5D055CEB"><gtr:id>A00C5921-6001-4D9E-8E10-EC2B5D055CEB</gtr:id><gtr:title>Flufenamic acid is a tool for investigating TRPC6-mediated calcium signalling in human conditionally immortalised podocytes and HEK293 cells.</gtr:title><gtr:parentPublicationTitle>Cell calcium</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b4d4923ca9efeb89ca05cb6f82d9603b"><gtr:id>b4d4923ca9efeb89ca05cb6f82d9603b</gtr:id><gtr:otherNames>Foster RR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0143-4160</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EA4A3D56-9C16-41A2-83F7-864DA1AE12D5"><gtr:id>EA4A3D56-9C16-41A2-83F7-864DA1AE12D5</gtr:id><gtr:title>Direct effects of dexamethasone on human podocytes.</gtr:title><gtr:parentPublicationTitle>Kidney international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/be2ec87babf6c01b527aac611ac38914"><gtr:id>be2ec87babf6c01b527aac611ac38914</gtr:id><gtr:otherNames>Xing CY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0085-2538</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/938A02C1-7F1F-428D-AAF7-D328F4CE1C29"><gtr:id>938A02C1-7F1F-428D-AAF7-D328F4CE1C29</gtr:id><gtr:title>Preeclamptic sera directly induce slit-diaphragm protein redistribution and alter podocyte barrier-forming capacity.</gtr:title><gtr:parentPublicationTitle>Nephron. Experimental nephrology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/20e624ebd7c3f8fcd1772503deaf8c51"><gtr:id>20e624ebd7c3f8fcd1772503deaf8c51</gtr:id><gtr:otherNames>Henao DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1660-2129</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/ED4D9F75-D7FE-48BB-82AC-D78E2A0610BF"><gtr:id>ED4D9F75-D7FE-48BB-82AC-D78E2A0610BF</gtr:id><gtr:title>Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/da69e7aef97805dc6d307020772ac16a"><gtr:id>da69e7aef97805dc6d307020772ac16a</gtr:id><gtr:otherNames>Manea M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/49F4711A-16E2-4423-8F78-E9BC05A2D1DF"><gtr:id>49F4711A-16E2-4423-8F78-E9BC05A2D1DF</gtr:id><gtr:title>Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy.</gtr:title><gtr:parentPublicationTitle>Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/52676be5fdecdd9c45da735a48da9ffc"><gtr:id>52676be5fdecdd9c45da735a48da9ffc</gtr:id><gtr:otherNames>Lai KN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0931-0509</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7DDAAA91-5AF8-4C99-BDDF-FD7099D7A466"><gtr:id>7DDAAA91-5AF8-4C99-BDDF-FD7099D7A466</gtr:id><gtr:title>Podocyte proteoglycan synthesis is involved in the development of nephrotic syndrome.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Renal physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/079caa6ca2df4153ac5a4914e7f3f847"><gtr:id>079caa6ca2df4153ac5a4914e7f3f847</gtr:id><gtr:otherNames>Bj?rnson Granqvist A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1522-1466</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D69AE21B-18C1-4372-9E55-867573F520DB"><gtr:id>D69AE21B-18C1-4372-9E55-867573F520DB</gtr:id><gtr:title>An in vitro model of the glomerular capillary wall using electrospun collagen nanofibres in a bioartificial composite basement membrane.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6dd13df02dff3a57d96aa97e2108a347"><gtr:id>6dd13df02dff3a57d96aa97e2108a347</gtr:id><gtr:otherNames>Slater SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/91DDE5E6-CF49-4530-8E0E-E49FE7FB4AF1"><gtr:id>91DDE5E6-CF49-4530-8E0E-E49FE7FB4AF1</gtr:id><gtr:title>The MIF receptor CD74 in diabetic podocyte injury.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d98e1263f6fa5867d8d4682299d97e68"><gtr:id>d98e1263f6fa5867d8d4682299d97e68</gtr:id><gtr:otherNames>Sanchez-Ni?o MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B5869C26-988B-425D-89A7-84EC1185476E"><gtr:id>B5869C26-988B-425D-89A7-84EC1185476E</gtr:id><gtr:title>Activation of podocytes by mesangial-derived TNF-alpha: glomerulo-podocytic communication in IgA nephropathy.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Renal physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/52676be5fdecdd9c45da735a48da9ffc"><gtr:id>52676be5fdecdd9c45da735a48da9ffc</gtr:id><gtr:otherNames>Lai KN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1522-1466</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/999BCA7D-7B09-4061-A2E4-90245462DC6D"><gtr:id>999BCA7D-7B09-4061-A2E4-90245462DC6D</gtr:id><gtr:title>Hemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/54ab7e3bb69e1fb68a55a57b0178c654"><gtr:id>54ab7e3bb69e1fb68a55a57b0178c654</gtr:id><gtr:otherNames>Lennon R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/12CFCBBE-3C79-4005-B1D0-8AE831DCD618"><gtr:id>12CFCBBE-3C79-4005-B1D0-8AE831DCD618</gtr:id><gtr:title>Nephrin is critical for the action of insulin on human glomerular podocytes.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b010d57a3f9726f685af57ca1e1cea7f"><gtr:id>b010d57a3f9726f685af57ca1e1cea7f</gtr:id><gtr:otherNames>Coward RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1E876A9D-EF84-46AF-B08E-643CD0233508"><gtr:id>1E876A9D-EF84-46AF-B08E-643CD0233508</gtr:id><gtr:title>Impact of diabetes on haemoglobin levels in renal disease.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7ff83f16d38aabf4bebe0647e4a76e18"><gtr:id>7ff83f16d38aabf4bebe0647e4a76e18</gtr:id><gtr:otherNames>Ravanan R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E11351F1-BE7F-4C21-BCF4-FF27CF4AF731"><gtr:id>E11351F1-BE7F-4C21-BCF4-FF27CF4AF731</gtr:id><gtr:title>The importance of cellular VEGF bioactivity in the development of glomerular disease.</gtr:title><gtr:parentPublicationTitle>Nephron. Experimental nephrology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b4d4923ca9efeb89ca05cb6f82d9603b"><gtr:id>b4d4923ca9efeb89ca05cb6f82d9603b</gtr:id><gtr:otherNames>Foster RR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1660-2129</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F9777838-9CBC-46DA-8190-CACB90996E03"><gtr:id>F9777838-9CBC-46DA-8190-CACB90996E03</gtr:id><gtr:title>The molecular and functional phenotype of glomerular podocytes reveals key features of contractile smooth muscle cells.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Renal physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/27b676a94efbdebd5ec821d522896233"><gtr:id>27b676a94efbdebd5ec821d522896233</gtr:id><gtr:otherNames>Saleem MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1522-1466</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1295913D-E6BE-4383-B355-F09F983CB8C8"><gtr:id>1295913D-E6BE-4383-B355-F09F983CB8C8</gtr:id><gtr:title>Inhalation of glutamic acid decarboxylase 65-derived peptides can protect against recurrent autoimmune but not alloimmune responses in the non-obese diabetic mouse.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7ff83f16d38aabf4bebe0647e4a76e18"><gtr:id>7ff83f16d38aabf4bebe0647e4a76e18</gtr:id><gtr:otherNames>Ravanan R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500053</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>2EEE0958-6BE1-4D16-B86B-5D954CD37219</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Renal and Urogenital</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>